Source:http://linkedlifedata.com/resource/pubmed/id/21551366
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2011-6-7
|
pubmed:abstractText |
IL-17A is a proinflammatory cytokine that has received attention for its role in the pathogenesis of several autoimmune diseases. IL-17A has also been implicated in cardiac and renal allograft rejection. Accordingly, we hypothesized that depletion of IL-17A would enhance corneal allograft survival. Instead, our results demonstrate that blocking IL-17A in a mouse model of keratoplasty accelerated the tempo and increased the incidence of allograft rejection from 50 to 90%. We describe a novel mechanism by which CD4(+)CD25(+) regulatory T cells (Tregs) respond to IL-17A and enhance corneal allograft survival. Our findings suggest the following: 1) IL-17A is necessary for ocular immune privilege; 2) IL-17A is not required for the induction of anterior chamber-associated immune deviation; 3) Tregs require IL-17A to mediate a contact-dependent suppression; 4) corneal allograft Tregs suppress the efferent arm of the immune response and are Ag specific; 5) Tregs are not required for corneal allograft survival beyond day 30; and 6) corneal allograft-induced Treg-mediated suppression is transient. Our findings identify IL-17A as a cytokine essential for the maintenance of corneal immune privilege and establish a new paradigm whereby interplay between IL-17A and CD4(+)CD25(+) Tregs is necessary for survival of corneal allografts.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1550-6606
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
186
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6737-45
|
pubmed:meshHeading |
pubmed-meshheading:21551366-Animals,
pubmed-meshheading:21551366-Antigens,
pubmed-meshheading:21551366-Corneal Transplantation,
pubmed-meshheading:21551366-Graft Rejection,
pubmed-meshheading:21551366-Graft Survival,
pubmed-meshheading:21551366-Immune System Phenomena,
pubmed-meshheading:21551366-Immunosuppressive Agents,
pubmed-meshheading:21551366-Interleukin-17,
pubmed-meshheading:21551366-Interleukin-2 Receptor alpha Subunit,
pubmed-meshheading:21551366-Mice,
pubmed-meshheading:21551366-T-Lymphocytes, Regulatory
|
pubmed:year |
2011
|
pubmed:articleTitle |
IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allografts.
|
pubmed:affiliation |
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|